# Glaxo Operations U.K. Ltd. – FDA Inspection, Sep 17, 2019

Source: https://www.keypedia.com/records/fda_inspections/glaxo-operations-uk-ltd/8391bdd5-8330-4bf7-97ff-df96b7424ec8
Source feed: FDA_Inspections

> FDA inspection 1107134 of Glaxo Operations U.K. Ltd., September 17, 2019. Classification: Voluntary Action Indicated (VAI). 9 citations under 21 CFR part 211. Form 483 issued. 10 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1107134
- Company Name: Glaxo Operations U.K. Ltd.
- Inspection Date: 2019-09-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: New Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 9

## Related Documents

- [FDA Inspection 1211398 - 2023-03-16](https://www.keypedia.com/records/fda_inspections/glaxo-operations-uk-ltd/beeed03d-92cd-4f68-97d4-c6f9a9109c7f)
- FDA Inspection 1209851 - 2023-02-10
- [FDA Inspection 1016930 - 2017-07-04](https://www.keypedia.com/records/fda_inspections/glaxo-operations-uk-ltd/6a8728a5-569f-4a0c-b014-af35693fbfc0)
- [FDA Inspection 1014765 - 2017-06-02](https://www.keypedia.com/records/fda_inspections/glaxo-operations-uk-ltd/650fa308-f844-4b69-aa5d-3e08cca79293)
- FDA Inspection 933676 - 2015-06-23

## Related Officers

- Issuing Officer
- [FDA Associated Person](https://www.keypedia.com/people/maya-m-davis/4180239e-5b21-4f9c-9ff0-6bbe5222f740)

Company: https://www.keypedia.com/companies/glaxo-operations-uk-ltd/5c8a39c9-a63a-4574-885a-c16948f20589

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8